<code id='A38BD9CCBF'></code><style id='A38BD9CCBF'></style>
    • <acronym id='A38BD9CCBF'></acronym>
      <center id='A38BD9CCBF'><center id='A38BD9CCBF'><tfoot id='A38BD9CCBF'></tfoot></center><abbr id='A38BD9CCBF'><dir id='A38BD9CCBF'><tfoot id='A38BD9CCBF'></tfoot><noframes id='A38BD9CCBF'>

    • <optgroup id='A38BD9CCBF'><strike id='A38BD9CCBF'><sup id='A38BD9CCBF'></sup></strike><code id='A38BD9CCBF'></code></optgroup>
        1. <b id='A38BD9CCBF'><label id='A38BD9CCBF'><select id='A38BD9CCBF'><dt id='A38BD9CCBF'><span id='A38BD9CCBF'></span></dt></select></label></b><u id='A38BD9CCBF'></u>
          <i id='A38BD9CCBF'><strike id='A38BD9CCBF'><tt id='A38BD9CCBF'><pre id='A38BD9CCBF'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:484

          On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on that note, we chat with our AI correspondent — and recent Pulitzer finalist — Casey Ross, who sat down on stage to discuss AI-centered drug discovery with both NVIDIA and Google-backed Isomorphic Labs.

          We also discuss this week’s biotech news, including yet more obesity drug data, this time from Roche, and the closing of Novartis’ acquisition of MorphoSys.

          advertisement

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          knowledge

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal
          Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Surge in Apellis stock fueled by confidence in safety of its eye drug

          MollyFerguson/STATSharesofApellisPharmaceuticalsarerebounding,drivenbyagrowingbeliefamongsomeinvesto